Related Experiment Video
Updated: Nov 6, 2025

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR-ERBB2 pathway
Deepti Bajpai1, Spencer Mehdizadeh1, Akihiko Uchiyama2
1Laboratory of Skin Biology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, USA.
Abstract:
Cutaneous squamous cell carcinoma (cSCC) ranks second in the frequency of all skin cancers. The balance between keratinocyte proliferation and differentiation is disrupted in the pathological development of cSCC. DLX3 is a homeobox transcription factor which plays pivotal roles in embryonic development and epidermal homeostasis. To investigate the impact of DLX3 expression on cSCC prognosis, we carried out clinicopathologic analysis of DLX3 expression which showed statistical correlation between tumors of higher pathologic grade and levels of DLX3 protein expression. Further, Kaplan-Meier survival curve analysis demonstrated that low DLX3 expression correlated with poor patient survival. To model the function of Dlx3 in skin tumorigenesis, a two-stage dimethylbenzanthracene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA) study was performed on mice genetically depleted of Dlx3 in skin epithelium (Dlx3cKO). Dlx3cKO mice developed significantly more tumors, with more rapid tumorigenesis compared to control mice. In Dlx3cKO mice treated only with DMBA, tumors developed after ~16 weeks suggesting that loss of Dlx3 has a tumor promoting effect. Whole transcriptome analysis of tumor and skin tissue from our mouse model revealed spontaneous activation of the EGFR-ERBB2 pathway in the absence of Dlx3. Together, our findings from human and mouse model system support a tumor suppressive function for DLX3 in skin and underscore the efficacy of therapeutic approaches that target EGFR-ERBB2 pathway.
Insights
DLX3 acts as a tumor suppressor in cutaneous squamous cell carcinoma (cSCC). Loss of DLX3 accelerates skin tumor development and activates the EGFR-ERBB2 pathway, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer.
- Disrupted keratinocyte proliferation and differentiation underlie cSCC development.
- DLX3, a homeobox transcription factor, is crucial for epidermal homeostasis.
Purpose of the Study:
- To investigate the role of DLX3 expression in cSCC prognosis.
- To model the function of Dlx3 in skin tumorigenesis.
- To identify molecular pathways affected by Dlx3 loss in cSCC.
Main Methods:
- Clinicopathologic analysis of DLX3 expression in human cSCC.
- Kaplan-Meier survival analysis.
- A two-stage DMBA/TPA skin tumorigenesis study in Dlx3 conditional knockout (Dlx3cKO) mice.
- Whole transcriptome analysis of mouse tumor and skin tissue.
Main Results:
- Higher DLX3 protein expression correlated with lower cSCC pathologic grade.
- Low DLX3 expression was associated with poor patient survival.
- Dlx3cKO mice exhibited increased tumor incidence and accelerated tumorigenesis.
- Loss of Dlx3 led to spontaneous activation of the EGFR-ERBB2 pathway.
Conclusions:
- DLX3 functions as a tumor suppressor in the skin.
- Therapeutic strategies targeting the EGFR-ERBB2 pathway may be effective for cSCC.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Mitogens and the Cell Cycle
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

